Mindbody Inc. (NASDAQ:MB) CEO Richard Lee Stollmeyer sold 21,760 shares of the business’s stock in a transaction that occurred on Monday, October 3rd. The stock was sold at an average price of $19.44, for a total transaction of $423,014.40. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.
Richard Lee Stollmeyer also recently made the following trade(s):
- On Thursday, September 1st, Richard Lee Stollmeyer sold 21,760 shares of Mindbody stock. The stock was sold at an average price of $17.35, for a total transaction of $377,536.00.
- On Monday, August 1st, Richard Lee Stollmeyer sold 21,760 shares of Mindbody stock. The stock was sold at an average price of $17.40, for a total transaction of $378,624.00.
Shares of Mindbody Inc. (NASDAQ:MB) opened at 19.84 on Wednesday. Mindbody Inc. has a 52 week low of $9.20 and a 52 week high of $20.38. The company’s market cap is $788.14 million. The firm has a 50-day moving average of $17.77 and a 200 day moving average of $15.68.
Mindbody (NASDAQ:MB) last released its earnings results on Wednesday, July 27th. The company reported ($0.10) EPS for the quarter, beating the consensus estimate of ($0.14) by $0.04. Mindbody had a negative net margin of 27.12% and a negative return on equity of 30.95%. The firm had revenue of $33.60 million for the quarter, compared to analyst estimates of $33.22 million. During the same period last year, the firm earned ($0.21) EPS. The business’s quarterly revenue was up 35.5% compared to the same quarter last year. Equities analysts anticipate that Mindbody Inc. will post ($0.44) earnings per share for the current fiscal year.
Institutional investors have recently added to or reduced their stakes in the stock. Royal Bank of Canada bought a new stake in Mindbody during the second quarter worth $4,043,000. Schwab Charles Investment Management Inc. bought a new stake in Mindbody during the second quarter worth $356,000. Metropolitan Life Insurance Co. NY bought a new stake in Mindbody during the second quarter worth $179,000. Caisse DE Depot ET Placement DU Quebec increased its stake in Mindbody by 37.3% in the second quarter. Caisse DE Depot ET Placement DU Quebec now owns 435,000 shares of the company’s stock worth $7,021,000 after buying an additional 118,225 shares during the last quarter. Finally, Capital World Investors bought a new stake in Mindbody during the second quarter worth $2,401,000. 38.49% of the stock is currently owned by hedge funds and other institutional investors.
A number of equities research analysts recently weighed in on MB shares. Imperial Capital started coverage on shares of Mindbody in a research note on Tuesday, June 7th. They set an “outperform” rating and a $18.00 price target for the company. Credit Suisse Group AG reaffirmed a “buy” rating on shares of Mindbody in a research note on Thursday, June 16th. Zacks Investment Research downgraded shares of Mindbody from a “buy” rating to a “hold” rating in a research note on Wednesday, July 6th. JMP Securities upped their target price on shares of Mindbody from $19.00 to $25.00 and gave the company a “market outperform” rating in a research note on Thursday, July 28th. Finally, Pacific Crest upped their target price on shares of Mindbody from $19.00 to $20.00 and gave the company an “overweight” rating in a research note on Thursday, July 28th. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $22.07.
Mindbody Company Profile
MINDBODY, Inc is a provider of cloud-based business management software for the wellness services industry and operates as a consumer marketplace with over 51,000 local business subscribers on its platform in over 130 countries and territories. The Company’s subscribers provide a range of wellness services to approximately 28 million active consumers.
Receive News & Ratings for Mindbody Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mindbody Inc. and related companies with MarketBeat.com's FREE daily email newsletter.